The award-winning mass spectrometer, introduced in June 2019, incorporates intelligent ‘designed-in’ innovations such as embedded sensors that monitor instrument health and provide early maintenance feedback.
Described by The Analytical Scientist as ‘a small, high-performance system that enables MS analysis without the requirement for extensive training,’ the Agilent InfinityLab LC/MSD iQ system is specifically designed for chemists and chromatographers, to be an easy-to-use mass selective detector that provides added specificity and selectivity.
“The pharma industry seems to be on the cusp of significant change,” said Stephanie Sutton, editor of The Medicine Maker. “Especially with the emergence of advanced medicines, such as cell and gene therapies, and new digital technologies with the potential to transform how the industry manufactures medicines – large and small. We’re proud to shine a light on the important contribution made by vendors to the manufacture of medicines and, ultimately, the treatment of patients.”
“Winning these two awards is especially gratifying, as it confirms the value of our continued emphasis on innovation,” said Monty Benefiel, Agilent vice president, and general manager of the company’s Mass Spectrometry Division. “It is our hope that the InfinityLab LC/MSD iQ system will help our customers do what they do best: improve the world around us.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.